Seres Therapeutics, Inc. financial data

Symbol
MCRB on Nasdaq
Industry
Pharmaceutical Preparations
Location
200 Sidney Street, Cambridge, MA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Seres Health, Inc. (to 5/14/2015)
Latest financial report
8-K - Q4 2023 - Aug 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 183 % -30.1%
Quick Ratio 37.2 %
Debt-to-equity -772 % -132%
Return On Equity 314 %
Return On Assets -46.7 % -1.7%
Operating Margin -42.2K % -36968%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 152M shares +18.4%
Common Stock, Shares, Outstanding 152M shares +18.4%
Entity Public Float 463M USD +93%
Common Stock, Value, Issued 152K USD +18.8%
Weighted Average Number of Shares Outstanding, Basic 152M shares +18.6%
Weighted Average Number of Shares Outstanding, Diluted 152M shares +16.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 374K USD -99.7%
Revenue from Contract with Customer, Excluding Assessed Tax 7.13M USD -95%
Research and Development Expense 94.7M USD -47.4%
General and Administrative Expense 68.7M USD -24.7%
Operating Income (Loss) -158M USD -6.34%
Nonoperating Income (Expense) -4.24M USD +14.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -162M USD -5.66%
Earnings Per Share, Basic -1.17 USD/shares +3.31%
Earnings Per Share, Diluted -1.17 USD/shares +3.31%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 71.2M USD -69%
Inventory, Net 53M USD +892%
Assets, Current 149M USD -40.6%
Property, Plant and Equipment, Net 17.8M USD -25.9%
Operating Lease, Right-of-Use Asset 103M USD -6.35%
Other Assets, Noncurrent 41.5M USD +269%
Assets 322M USD -20.8%
Accounts Payable, Current 4.81M USD -62.8%
Employee-related Liabilities, Current 7.44M USD -36.4%
Liabilities, Current 108M USD +39%
Operating Lease, Liability, Noncurrent 101M USD -5.41%
Other Liabilities, Noncurrent 1.73M USD +12.9%
Liabilities 409M USD +6.52%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -1.05B USD -18.2%
Stockholders' Equity Attributable to Parent -87.1M USD -485%
Liabilities and Equity 322M USD -20.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -35.2M USD +54%
Net Cash Provided by (Used in) Financing Activities 18.8M USD +232%
Net Cash Provided by (Used in) Investing Activities -62K USD -102%
Common Stock, Shares Authorized 360M shares +50%
Common Stock, Shares, Issued 152M shares +18.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -68.2M USD -156%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 81.1M USD -65.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.58M USD +106%
Deferred Tax Assets, Valuation Allowance 313M USD +12.8%
Deferred Tax Assets, Gross 342M USD +11.4%
Operating Lease, Liability 110M USD -1.82%
Payments to Acquire Property, Plant, and Equipment 62K USD -98.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -162M USD -5.84%
Lessee, Operating Lease, Liability, to be Paid 168M USD -7.94%
Property, Plant and Equipment, Gross 71.6M USD -0.53%
Operating Lease, Liability, Current 9.2M USD +68.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 22.7M USD +5.19%
Lessee, Operating Lease, Liability, to be Paid, Year One 22.1M USD +13.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 58.3M USD -17.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 23.3M USD +5.38%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD +7.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 13.5M USD +7.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 23.6M USD
Operating Lease, Payments 17.3M USD +48.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.3M USD -0.1%
Share-based Payment Arrangement, Expense 25.8M USD -24.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%